337 related articles for article (PubMed ID: 28692484)
21. Contrast volume to estimated glomerular filtration rate ratio for prediction of contrast-induced acute kidney injury after cardiac catheterization in adults with congenital heart disease.
Gellis L; Gauvreau K; Ferguson M; Bergersen L; Shafer K; Porras D
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1301-1308. PubMed ID: 30196559
[TBL] [Abstract][Full Text] [Related]
22. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Keach JW; Stanislawski MA; Barón AE; Plomondon ME; Langner P; Amin A; Gilmartin HM; Waldo S; Maddox TM
BMC Nephrol; 2020 Apr; 21(1):150. PubMed ID: 32345254
[TBL] [Abstract][Full Text] [Related]
23. Tailored Versus Standard Hydration to Prevent Acute Kidney Injury After Percutaneous Coronary Intervention: Network Meta-Analysis.
Moroni F; Baldetti L; Kabali C; Briguori C; Maioli M; Toso A; Brilakis ES; Gurm HS; Bagur R; Azzalini L
J Am Heart Assoc; 2021 Jul; 10(13):e021342. PubMed ID: 34169747
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis in High-Risk Patients With eGFR < 30 mL/min/1.73 m2: Get the Balance Right.
Nijssen EC; Nelemans PJ; Rennenberg RJ; Theunissen RA; van Ommen V; Wildberger JE
Invest Radiol; 2019 Sep; 54(9):580-588. PubMed ID: 31033672
[TBL] [Abstract][Full Text] [Related]
26. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials.
Sadat U; Usman A; Gillard JH; Boyle JR
J Am Coll Cardiol; 2013 Dec; 62(23):2167-75. PubMed ID: 23994417
[TBL] [Abstract][Full Text] [Related]
27. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ; Reimer P; Dekkers IA; Bongartz G; Bellin MF; Bertolotto M; Clement O; Heinz-Peer G; Stacul F; Webb JAW; Thomsen HS
Eur Radiol; 2018 Jul; 28(7):2856-2869. PubMed ID: 29417249
[TBL] [Abstract][Full Text] [Related]
28. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Napolitano G; Focaccio A;
Catheter Cardiovasc Interv; 2020 Apr; 95(5):895-903. PubMed ID: 31282129
[TBL] [Abstract][Full Text] [Related]
29. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
Dai B; Liu Y; Fu L; Li Y; Zhang J; Mei C
Am J Kidney Dis; 2012 Sep; 60(3):360-70. PubMed ID: 22516682
[TBL] [Abstract][Full Text] [Related]
30. Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Renal Insufficiency.
Liu Y; Li H; Chen S; Chen J; Tan N; Zhou Y; Liu Y; Ye P; Ran P; Duan C; Chen P
J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27233298
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.
Martin-Moreno PL; Varo N; Martínez-Ansó E; Martin-Calvo N; Sayón-Orea C; Bilbao JI; Garcia-Fernandez N
Nephron; 2015; 131(1):51-8. PubMed ID: 26336919
[TBL] [Abstract][Full Text] [Related]
33. Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: A systematic review and trial sequential analysis.
Wang N; Qian P; Yan TD; Phan K
Int J Cardiol; 2016 Mar; 206():143-52. PubMed ID: 26797158
[TBL] [Abstract][Full Text] [Related]
34. How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?
Dong Y; Zhang B; Liang L; Lian Z; Liu J; Liang C; Zhang S
Medicine (Baltimore); 2016 Feb; 95(7):e2715. PubMed ID: 26886610
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): a study protocol for a randomized controlled trial.
Jo HA; Park S; Kim CD; Jung HY; Cho JH; Cha RH; Kang EW; Chang TI; Kim S; Kim HJ; Chung BH; Lee JP; Park JT; Han SH; Yoo TH; Ryu DR; Moon SJ; Chang JH; Kim DK; Joo KW
Trials; 2017 Oct; 18(1):461. PubMed ID: 28982378
[TBL] [Abstract][Full Text] [Related]
36. Preventing contrast-induced acute kidney injury with probucol and hydration in patients with coronary heart disease: A systematic review and meta-analysis of randomized controlled trials.
Cui X; Xie B; Wang H; Liu F; Mei L; Qin F; Zhang J; Yi X
Medicine (Baltimore); 2023 Mar; 102(11):e33273. PubMed ID: 36930109
[TBL] [Abstract][Full Text] [Related]
37. Probucol for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary intervention: A meta-analysis of randomized controlled trials
.
Xin W; Lin Z; Zhang T; Jia S
Clin Nephrol; 2019 Jul; 92(1):36-43. PubMed ID: 30964433
[TBL] [Abstract][Full Text] [Related]
38. Contrast Induced Acute Kidney Injury and its Impact on Mid-Term Kidney Function, Cardiovascular Events and Mortality.
Ribitsch W; Horina JH; Quehenberger F; Rosenkranz AR; Schilcher G
Sci Rep; 2019 Nov; 9(1):16896. PubMed ID: 31729409
[TBL] [Abstract][Full Text] [Related]
39. Safe Hydration Volume to Prevent Contrast-induced Acute Kidney Injury and Worsening Heart Failure in Patients With Heart Failure and Preserved Ejection Fraction After Cardiac Catheterization.
Bei WJ; Wang K; Li HL; Lin KY; Guo XS; Chen SQ; Liu Y; Yi SX; Luo DM; Chen JY; Tan N
J Cardiovasc Pharmacol; 2017 Sep; 70(3):168-175. PubMed ID: 28525419
[TBL] [Abstract][Full Text] [Related]
40. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
